Rare diseases
Investigational molecules
Locations
74 Noryangjin-Ro, Dongjak-Gu, 06927
Clinical research in non-small cell lung cancer, with a focus on adenocarcinoma of the lung that is locally advanced or metastatic and not suitable for curative surgery or radiotherapy. The studies examine targeted treatment options for advanced disease.
The oncology portfolio is centered on treatment efficacy in advanced lung cancer settings.
Yuhan Corp. runs clinical trials in conditions such as Chronic spontaneous urticaria, Lung adenocarcinoma stage III, Lung adenocarcinoma stage IV, Non-small cell lung cancer metastatic, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Bulgaria
GreeceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
